Stoke Therapeutics, Inc. earnings per share and revenue

STOK earnings per share for the last quarter are -0.18 USD whereas the estimation was -0.53 USD which accounts for 65.92% surprise. Company revenue for the same period amounts to 22.61 M USD despite the estimated figure of 4.28 M USD. Estimated earnings per share for the next quarter are 0.20 USD, and revenue is expected to reach 33.08 M USD. Also watch annual changes over time to get a bigger picture of STOK earnings per share and revenue dynamics.